Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine whether alternative agents (e.g. artificial platelet substitutes, platelet-poor plasma, fibrinogen, rFVIIa, thrombopoietin mimetics) are as effective and safe as the use of platelet transfusions f...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Estcourt, Lise J, Gregg, Richard, Stanworth, Simon, Doree, Carolyn, Trivella, Marialena, Murphy, Michael F, Tinmouth, Alan
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4338548/
https://ncbi.nlm.nih.gov/pubmed/25722650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010982
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky